 |
|
|
|
|
|
|
|
|
|
|
|
1 to 9 of 9 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Multhaup G. on PAPER: Winton MJ. et al., 2011, The intraneuronal pool of Aβ may have a double origin, which should be incorporated in the... 14 Jun 2011.
|
|
|
 |
|
|
Multhaup G. on PAPER: He G. et al., 2010, Regulated intramembrane proteolysis (RIP) is currently the hot topic in the field of proteases,... 3 Sep 2010.
|
|
|
|
|
|
Multhaup G. on NEWS: The Toxic Fold? Aβ Dodecamers, Tetramers Show Their Conformations, We readily agree with some of the data and interpretations given in the interesting paper of... 16 Jun 2009.
|
|
|
|
|
|
Multhaup G. on PAPER: Hung LW. et al., 2008, The paper by Hung et al. adds interesting new aspects to the prevalent hypothesis that Aβ... 18 Nov 2008.
|
|
|
|
|
|
Multhaup G. on PAPER: Schneider A. et al., 2008, APP is subject to two alternative cleavages: a potentially amyloidogenic pathway and a... 21 Mar 2008.
|
|
|
|
|
|
Multhaup G. on NEWS: Paper Alert: Pathology Reversed by Abolishing APP Caspase Site, I have read this article with great interest since I believe it is always refreshing to hear... 26 May 2006.
|
|
|
|
|
|
Multhaup G. on NEWS: Dangerous Liaisons—Tau and Aβ, Together at Last?, Guo et al. have found that tau and amyloid-β can interact in vitro. The authors used a mix of... 27 Jan 2006.
|
|
|
|
|
|
Multhaup G, Munter L. on PAPER: Marchesi VT. et al., 2005, We have done experimental work on the GxxxG motif of APP since we realized, almost 3 years ago,... 2 Dec 2005.
|
|
|
|
|
|
Multhaup G, Munter L. on LIVE DISCUSSION: Messing with the Membrane—An Alternative Interpretation of the Amyloid-β Hypothesis, We have done experimental work on the GxxxG motif of APP since we realized, almost 3 years ago,... 2 Dec 2005.
|
|
|
|
|
|
|
1 to 9 of 9 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
Check out our upcoming Webinar: 
